Literature DB >> 33652837

Synthesis of Highly Potent Anti-Inflammatory Compounds (ROS Inhibitors) from Isonicotinic Acid.

Sana Yaqoob1, Nourina Nasim1, Rahila Khanam1, Yan Wang1, Almas Jabeen2, Urooj Qureshi1, Zaheer Ul-Haq1,2, Hesham R El-Seedi3,4,5, Zi-Hua Jiang6, Farooq-Ahmad Khan1.   

Abstract

In search of anti-inflammatory compounds, novel scaffolds containing isonicotinoyl motif were synthesized via an efficient strategy. The compounds were screened for their in vitro anti-inflammatory activity. Remarkably high activities were observed for isonicotinates 5-6 and 8a-8b. The compound 5 exhibits an exceptional IC50 value (1.42 ± 0.1 µg/mL) with 95.9% inhibition at 25 µg/mL, which is eight folds better than the standard drug ibuprofen (11.2 ± 1.9 µg/mL). To gain an insight into the mode of action of anti-inflammatory compounds, molecular docking studies were also performed. Decisively, further development and fine tuning of these isonicotinates based scaffolds for the treatment of various aberrations is still a wide-open field of research.

Entities:  

Keywords:  ROS inhibitors; anti-inflammatory; isonicotinic acid; molecular docking studies; pyridine carboxylic acid

Mesh:

Substances:

Year:  2021        PMID: 33652837      PMCID: PMC7956706          DOI: 10.3390/molecules26051272

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  18 in total

Review 1.  Targeting histone demethylase KDM5B for cancer treatment.

Authors:  Yun-Dong Fu; Ming-Jie Huang; Jia-Wen Guo; Ya-Zhen You; Hong-Min Liu; Li-Hua Huang; Bin Yu
Journal:  Eur J Med Chem       Date:  2020-08-21       Impact factor: 6.514

2.  Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation.

Authors:  Daniela Corrêa Santos; Ruan Roberto Henriques; Marcos Antonio de Abreu Lopes Junior; André Borges Farias; Thayssa Lisboa do Couto Nogueira; João Victor Fernandes Quimas; Nelilma Correia Romeiro; Leandro Louback da Silva; Andréa Luzia Ferreira de Souza
Journal:  Bioorg Med Chem       Date:  2020-03-31       Impact factor: 3.641

3.  Novel phthalide derivatives: Synthesis and anti-inflammatory activity in vitro and in vivo.

Authors:  Liu Zeng Chen; Jing Wu; Kang Li; Qian Qian Wu; Rui Chen; Xin Hua Liu; Ban Feng Ruan
Journal:  Eur J Med Chem       Date:  2020-08-14       Impact factor: 6.514

4.  Anti-inflammatory, analgesic, anticonvulsant and antiparkinsonian activities of some pyridine derivatives using 2,6-disubstituted isonicotinic acid hydrazides.

Authors:  Mohamed A Al-Omar; Abd El-Galil E Amr; Rashad A Al-Salahi
Journal:  Arch Pharm (Weinheim)       Date:  2010-11       Impact factor: 3.751

5.  New one-pot synthesis of anti-tuberculosis compounds inspired on isoniazid.

Authors:  Diego G Ghiano; Alejandro Recio-Balsells; Ana Bortolotti; Lucas A Defelipe; Adrián Turjanski; Héctor R Morbidoni; Guillermo R Labadie
Journal:  Eur J Med Chem       Date:  2020-08-22       Impact factor: 6.514

6.  Synthesis of some new 1,2,4-triazoles starting from isonicotinic acid hydrazide and evaluation of their antimicrobial activities.

Authors:  Hacer Bayrak; Ahmet Demirbas; Neslihan Demirbas; Sengül Alpay Karaoglu
Journal:  Eur J Med Chem       Date:  2009-05-28       Impact factor: 6.514

7.  Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregation.

Authors:  Xuyi Yue; Dhruva D Dhavale; Junfeng Li; Zonghua Luo; Jialu Liu; Hao Yang; Robert H Mach; Paul T Kotzbauer; Zhude Tu
Journal:  Bioorg Med Chem Lett       Date:  2018-02-16       Impact factor: 2.823

8.  Synthesis, in vitro and in vivo pharmacological evaluation of serotoninergic ligands containing an isonicotinic nucleus.

Authors:  Ferdinando Fiorino; Antonio Ciano; Elisa Magli; Beatrice Severino; Angela Corvino; Elisa Perissutti; Francesco Frecentese; Paola Di Vaio; Angelo A Izzo; Raffaele Capasso; Paola Massarelli; Cristina Nencini; Ilaria Rossi; Ewa Kędzierska; Jolanta Orzelska-Gòrka; Anna Bielenica; Vincenzo Santagada; Giuseppe Caliendo
Journal:  Eur J Med Chem       Date:  2016-01-18       Impact factor: 6.514

Review 9.  ROS in cancer therapy: the bright side of the moon.

Authors:  Bruno Perillo; Marzia Di Donato; Antonio Pezone; Erika Di Zazzo; Pia Giovannelli; Giovanni Galasso; Gabriella Castoria; Antimo Migliaccio
Journal:  Exp Mol Med       Date:  2020-02-14       Impact factor: 8.718

10.  Development of 2-(4-pyridyl)-benzimidazoles as PKN2 chemical tools to probe cancer.

Authors:  Fiona Scott; Angela M Fala; Lewis E Pennicott; Tristan D Reuillon; Katlin B Massirer; Jonathan M Elkins; Simon E Ward
Journal:  Bioorg Med Chem Lett       Date:  2020-02-17       Impact factor: 2.823

View more
  3 in total

Review 1.  Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors.

Authors:  Mohsen Ahmadi; Sander Bekeschus; Klaus-Dieter Weltmann; Thomas von Woedtke; Kristian Wende
Journal:  RSC Med Chem       Date:  2022-02-14

Review 2.  The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design.

Authors:  Yong Ling; Zhi-You Hao; Dong Liang; Chun-Lei Zhang; Yan-Fei Liu; Yan Wang
Journal:  Drug Des Devel Ther       Date:  2021-10-13       Impact factor: 4.162

Review 3.  Small molecule compounds with good anti-inflammatory activity reported in the literature from 01/2009 to 05/2021: a review.

Authors:  Ming Bian; Qian-Qian Ma; Yun Wu; Huan-Huan Du; Gong Guo-Hua
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.